2013Sichuan Medical JournalRequires access

Simultaneous surgical management of Benign prostatic hyperplasia and bladder tumor.

LI Jian-yon

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of simultaneous transurethral resection for patients with benign prostatic hyperplasia(BPH) and bladder transitional cell carcinoma.Methods 35 patients with bladder transitional cell carcinoma and BPH were treated by transurethral plasmakinetic resection at the same time.All patients were follewed up.Results No transurethral resection syndrome occurred in those patients.The peak flow rate increased from(5.6 ±3.4) mL / s to((15.2 ±3.8)) mL / s,the international prostate symptom score(IPSS) decreased from(23.6±7.2) to(10.1±0.9) at postoperative 6 months respectively and made differnce P0.05.The patients were followed up ranged from 6 ~ 50 months.3 cases showed rucurent bladder tumors.Conclusion Transurethral plasmakinetic resection simultaneous is safe and effective for the patients with bladder tumor coexisting BPH,while no effect on incidence of implantation in bladder neck and prostatic fossa.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of simultaneous transurethral resection for patients with benign prostatic hyperplasia(BPH) and bladder transitional cell carcinoma.Methods 35 patients with bladder transitional cell carcinoma and BPH were treated by transurethral plasmakinetic resection at the same time.All patients were follewed up.Results No transurethral resection syndrome occurred in those patients.The peak flow rate increased from(5.6 ±3.4) mL / s to((15.2 ±3.8)) mL / s,the international prostate symptom score(IPSS) decreased from(23.6±7.2) to(10.1±0.9) at postoperative 6 months respectively and made differnce P0.05.The patients were followed up ranged from 6 ~ 50 months.3 cases showed rucurent bladder tumors.Conclusion Transurethral plasmakinetic resection simultaneous is safe and effective for the patients with bladder tumor coexisting BPH,while no effect on incidence of implantation in bladder neck and prostatic fossa.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of simultaneous transurethral resection for patients with benign prostatic hyperplasia(BPH) and bladder transitional cell carcinoma.Methods 35 patients with bladder transitional cell carcinoma and BPH were treated by transurethral plasmakinetic resection at the same time.All patients were follewed up.Results No transurethral resection syndrome occurred in those patients.The peak flow rate increased from(5.6 ±3.4) mL / s to((15.2 ±3.8)) mL / s,the international prostate symptom score(IPSS) decreased from(23.6±7.2) to(10.1±0.9) at postoperative 6 months respectively and made differnce P0.05.The patients were followed up ranged from 6 ~ 50 months.3 cases showed rucurent bladder tumors.Conclusion Transurethral plasmakinetic resection simultaneous is safe and effective for the patients with bladder tumor coexisting BPH,while no effect on incidence of implantation in bladder neck and prostatic fossa.

Key concepts: Medicine, Hyperplasia, Urology, Resection, Neck of urinary bladder, Prostate, Transurethral resection of the prostate, Bladder tumor

Related papers

Back to paper searchBrowse research topicsOriginal source
Simultaneous surgical management of Benign prostatic hyperplasia and bladder tumor. — Research Paper | ScholarLens